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Abstract: Hospital-at-home (HaH) is a healthcare modality that provides active treatment by
healthcare staff in the patient’s home for a condition that would otherwise require hospitalization.
The aims were to describe the characteristics of different types of hospital-at-home (HaH), assess their
results, and examine which factors could be related to these results. A cross-sectional study based on
data from all 2014 HaH contacts from Catalonia was designed. The following HaH modalities were
considered—admission avoidance (n = 7214; 75.1%) and early assisted discharge (n = 2387; 24.9%).
The main outcome indicators were readmission, mortality, and length of stay (days). Multivariable
models were fitted to assess the association between explanatory factors and outcomes. Hospital
admission avoidance is a scheme in which, instead of being admitted to acute care hospitals, patients
are directly treated in their own homes. Early assisted discharge is a scheme in which hospital
in-care patients continue their treatment at home. In the hospital avoidance modality, there were 8.3%
readmissions, 0.9% mortality, and a mean length of stay (SD) of 9.6 (10.6) days. In the early assisted
discharge modality, these figures were 7.9%, 0.5%, and 9.8 (11.1), respectively. In both modalities,
readmission and mean length of stay were related to comorbidity and type of hospital, and mortality
with age. The results of HaH in Catalonia are similar to those observed in other contexts. The factors
related to these results identified might help to improve the effectiveness and efficiency of the different
HaH modalities.
Keywords: hospital-at-home; readmission; mortality; average stay; cross-sectional study
1. Introduction
Hospital-at-home (HaH) is a healthcare modality that, for a limited period of time, provides
active treatment by healthcare staff in the patient’s home for a condition that would otherwise require
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hospitalization [1–4]. Unlike other home care services that are focused on less severe patients and are
carried out by primary care staff, HaH is specialized (secondary) care and, therefore, is performed
by different hospital specialists. Previous studies have described two basic types of HaH: hospital
admission avoidance and early assisted discharge [5–7]. The admission avoidance model is usually
employed with elderly individuals who, instead of being admitted to acute care hospitals, are treated
at home [6,8,9]. The model mainly focuses on short-term interventions (days) for the acute phase of
an illness. With respect to admission to this HaH modality, patients are mostly included after being
attended by emergency services or, less commonly, after a referral from their family doctor. In contrast,
the early assisted discharge HaH model is for hospitalized patients who are able to continue their
treatment at home, thus reducing the duration of their stay [7].
Within the context of Catalonia, since 1985, the HaH model has been officially recognized as a
healthcare activity or service. In spite of this legal framework, the posterior evolution of the healthcare
system within the territory has not led to the program’s homogenous development [8,10–14]. This has
resulted in the appearance of HaH units without any pre-established or defined resource structures and
with varying service portfolios, all of which have hindered a common evaluation. Nevertheless, in spite
of the lack of homogeneity, the patients included in HaH programs can be categorized according to two
modalities: hospital admission avoidance and early assisted discharge. Although such a classification
is very general [5–7,14], it does permit an evaluation of their respective results at a population level
and the determination of factors potentially related to each of the modalities. The delimitation of the
factors associated with such results for each modality in a particular context might allow populations
that could have a higher potential benefit of receiving this attention to be defined. This identification
could be the first step for causal research to define and establish the most effective and efficient
healthcare circuits, thus helping to improve the modalities’ results and avoiding unnecessary costs to
the healthcare systems.
The objectives of this study were: (1) to describe the contact characteristics of both HaH modalities
(admission avoidance and early assisted discharge) in Catalonia during 2014; (2) to evaluate the rates
of readmission, mortality, and mean length of stay for each of the modalities; and (3) to examine which
factors could be related to their results.
2. Experimental Section
2.1. Study Design and Population
An exploratory cross-sectional study based on the Minimum Basic Data Set from Acute-care
Hospitals (MBDSHA) was performed. The MBDSHA included 24 public hospitals in the Catalonian
territory and HaH contacts for 2014 [15]. A contact was every time a patient received any kind
of treatment from commencement to finalization. The same individual could present more than
one contact during the study period. Programmed contacts with a specific diagnosis according to
the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) were
included (n = 9805) [16]. Those who belonged to a diagnostic group with an insufficient number of
contacts for robustness (n = 95, 1.0%), lacked an identification number (n = 49, 0.5%), had no established
age (n = 2, <0.1%), and whose dates of admission and discharge were wrongly codified (58, 0.6%),
were excluded. Finally, a total sample of 9601 HaH contacts was considered for analysis—7214 (75.1%)
admission avoidance and 2387 (24.9%) early assisted discharge.
2.2. Main Outcomes
Three indicators were established as the main outcomes for the exploratory analysis. These
indicators were selected both based on their relevance to assessing the performance of the HaH
modalities, as well as based on the recommendations for the assessment of HaH from previous
systematic reviews [6,7].
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Readmission: based on the definition of the Centers for Medicare and Medicaid Services (CMS) [17],
this indicator was defined as a consecutive HaH contact, either HaH or conventional hospitalization
(CH), related to the first HaH attention in a period ≤ 30 days starting from 1 January 2014 up to 30
January 2015 (to consider those contacts from December 2014).
Mortality prior to discharge: HaH contacts in which the patient status at discharge was death.
Mean length of stay: for the admission avoidance modality, duration (days) of HaH contact
from the date of program admission to finalization. For early assisted discharge, the duration was
a combination of the immediately preceding contact of CH and the HaH one, taking it from the CH
contact date of admission to HaH finalization.
2.3. Contact Characteristics
1. Sex: male and female.
2. Age (years): considered a continuous variable.
3. Diagnosis: categorized according to the ICD-9-CM chapters [16].
4. Comorbidity according to the Charlson Comorbidity Index (CCI) [18,19]. The CCI, considered to
be an objective measurement of an individual’s general state of health, is employed to predict
mortality in terms of the patient’s comorbidity. General comorbidity is calculated through the
weight assigned to the presence of each of the 19 conditions making up the index. The results are
classified as 0 or 1, 2, and ≥3.
5. Type of hospital (according to the portfolio of services offered in the hospital itself, irrespective of
the patient’s territorial assignment): reference hospital, district hospital, general high-technology
hospital, and high-resolution hospital.
6. Number of contacts per patient (number of HaH episodes): 1 or more than 1.
2.4. Data Analysis
A descriptive analysis of the characteristics of the contacts according to the HaH modality was
performed and the results were evaluated at the bivariable level. To compare the possible differences
in the explicative variables between the two modalities, Chi-square and Fisher’s exact tests were
employed for the categorical variables, and the Mann–Whitney U test for age and mean length of stay
due to the lack of normality of their distributions. The selected outcomes were then calculated for each
modality and the association between the contacts’ characteristics, and each of these indicators was
assessed with multivariable models. Due to the characteristics of the variables considered as outcomes,
logistic regression models were fitted for readmission and mortality, and Poisson models for mean
length of stay. From these results, the β coefficients and their respective 95% confidence intervals (95%
CI) were obtained, and their exponential was presented to aid interpretation (the Odds Ratio in logistic
regression models and ratios for Poisson models). All multivariable models were done individually
for the two HaH modalities and adjusted for sex, age, comorbidity (CCI), and the type of hospital.
The absence of relevant interactions between explanatory variables was tested using a Chunk test. All
analyses were carried out with the STATA v.14® (StataCorp, College Station, TX, US) [20] software and
statistical significance was set to α = 0.05.
3. Results
Table 1 shows the contacts’ characteristics in terms of their HaH modality. The contact frequency
for admission avoidance during 2014 in Catalonia (n = 7214) was greater than that of early assisted
discharge (n = 2387). Differences were observed between the two HaH modalities for sex, diagnostic
group, and type of hospital. The diagnostic groups with the most contacts were diseases of the
respiratory system. With respect to the indicators calculated for each of the HaH modalities (Table 2),
while significant differences were not found for readmissions or for mean length of stay, differences
(p = 0.04) in mortality before discharge were found.
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Table 1. Characteristics of the contacts, hospital, and care process according to the hospital-at-home modality.
Admission Avoidance
(n = 7214)
Early Discharge
(n = 2387) p Value
n (%) n (%)
Mean age in years (SD) 69.9 (17.2) 69.6 (16.8) 0.309
Sex 0.013
Male 3800 (52.7) 1327 (55.6)
Female 3414 (47.3) 1060 (44.4)
Diagnostic group <0.001
Respiratory system diseases 2440 (33.8) 780 (32.7)
Genitourinary system diseases 976 (13.5) 412 (17.3)
Circulatory system diseases 1030 (14.3) 234 (9.8)
Osteomioarticular and connective tissue system
diseases 747 (10.4) 137 (5.7)
Lesions and intoxications 499 (6.9) 250 (10.5)
Digestive tract diseases 470 (6.5) 268 (11.2)
Skin and subcutaneous tissue diseases 363 (5.0) 79 (3.3)
Neoplasms 247 (3.4) 53 (2.2)
Central nervous system and sense organ
diseases 131 (1.8) 62 (2.6)
Badly defined symptoms, signs, and conditions 138 (1.9) 46 (1.9)
Endocrine, nutritional and metabolic diseases,
and immunity disorders 106 (1.5) 42 (1.8)
Blood and hematopoietic organ diseases 67 (0.9) 24 (1.0)
Comorbidity (Charlson Index) 0.626
0 or 1 4479 (62.1) 1477 (61.9)
2 1168 (16.2) 405 (17.0)
≥ 3 1567 (21.7) 505 (21.2)
Type of hospital <0.001
Reference hospital 2673 (37.1) 534 (22.4)
District hospital 2322 (32.2) 738 (30.9)
High-technology general hospital 1029 (14.3) 608 (25.5)
High-resolution reference hospital 1190 (16.5) 507 (21.2)
Number of contacts per patient 0.254
1 5383 (74.6) 1809 (75.8)
>1 1831 (25.4) 578 (24.2)
n: number of contacts; %: percentage of contacts; SD: standard deviation. p: p-value obtained with Chi-square test
and Fisher’s test for categorical variables, and Mann–Whitney U for age.
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Table 2. Readmission, mortality, and mean length of stay according to the hospital-at-home modality.
Admission Avoidance
(n = 7214)
Early Discharge
(n = 2387) p-Value
n (%) n (%)
Readmission 0.524
No 6613 (91.7) 2198 (92.1)
Yes 601 (8.3) 189 (7.9)
Mortality prior to discharge 0.040
No exitus 7146 (99.1) 2375 (99.5)
Exitus 68 (0.9) 12 (0.5)
Mean contact stay (SD) in days 9.6 (10.6) 9.8 (11.1) 0.059
Total days of stay 68,934 23,460
n: number of contacts; %: percentage of contacts; SD: standard deviation. p: p-value obtained with the Chi-square
test and Fisher’s test for categorical variables, and Mann–Whitney U for mean length of stay.
Table 3 shows that in the admission avoidance, readmission was related to a CCI ≥3 (exp(β):
1.69; CI95%: 1.39–2.07), type of hospital, and age (exp(β): 1.02; CI95%: 1.01–1.02); mortality prior to
discharge was related to a CCI ≥3 (exp(β): 1.89; CI95%: 1.08–3.31), to be treated in a high-resolution
hospital (exp (β): 2.11; CI95%: 1.04–4.27), and age (exp (β): 1.07; CI95%: 1.05–1.10). The mean length
of stay was greater in women than in men (exp(β): 0.94; CI95%: 0.92–0.96), and was related to the CCI,
type of hospital, and age. For the early assisted discharge modality, readmission was related to the CCI
and type of hospital, mortality was associated with age (exp (β): 1.11; CI95%: 1.04–1.20), and the mean
length of stay was related to sex, having a CCI ≥3 (exp (β): 1.07; CI95%: 1.03–1.10), type of hospital,
and age.
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Table 3. Factors related to readmission, mortality, and mean length of stay according to the hospital-at-home modality.
Readmission Mortality Prior to Discharge Mean Length of Stay
n % aOR (CI95%) p n % aOR (CI95%) p mean SD Ratio (CI95%) p
Admission avoidance
Sex
Male 302 8.0 1.00 37 1.0 1.00 9.9 11.3 1.00
Female 299 8.8 1.17 (0.99–1.39) 0.065 31 0.9 0.87 (0.53–1.44) 0.582 9.1 9.8 0.94 (0.92–0.96) <0.001
Charlson Index
0 or 1 304 6.8 1.00 28 0.6 1.00 8.8 10.0 1.00
2 108 9.3 1.22 (0.97–1.55) 0.083 16 1.4 1.67 (0.90–3.11) 0.106 10.6 12.3 1.20 (1.18–1.22) <0.001
≥ 3 189 12.1 1.69 (1.39–2.07) <0.001 24 1.5 1.89 (1.08–3.31) 0.027 10.8 10.6 1.26 (1.24–1.28) <0.001
Type of hospital
Reference hospital 156 5.8 1.00 15 0.6 1.00 9.6 10.4 1.00
District hospital 217 9.4 1.48 (1.19–1.83) <0.001 28 1.2 1.54 (0.81–2.91) 0.182 7.1 5.7 0.74 (0.72–0.75) <0.001
High-technology general hospital 106 10.3 1.62 (1.25–2.11) <0.001 8 0.8 1.01 (0.43–2.40) 0.975 11.7 11.4 1.19 (1.17–1.22) <0.001
High-resolution hospital 122 10.3 1.76 (1.37–2.27) <0.001 17 1.4 2.11 (1.04–4.27) 0.037 12.4 15.5 1.30 (1.27–1.33) <0.001
Age 1.02 (1.01–1.02) <0.001 1.07 (1.05–1.10) <0.001 1.00 (1.00–1.00) <0.001
Early discharge
Sex
Male 117 8.8 1.00 5 0.4 1.00 9.8 8.7 1.00
Female 72 6.8 0.82 (0.60–1.12) 0.212 7 0.7 1.23 (0.34–4.04) 0.729 9.9 13.5 1.06 (1.04–1.09) <0.001
Charlson Index
0 or 1 93 6.3 1.00 8 0.5 1.00 9.7 10.8 1.00
2 46 11.4 1.70 (1.16–2.45) 0.006 3 0.7 1.04 (0.27–3.99) 0.954 9.8 12.3 1.00 (0.97–1.05) 0.596
≥ 3 50 9.9 1.52 (1.05–2.21) 0.028 1 0.2 0.28 (0.03–2.29) 0.235 10.2 11.1 1.07 (1.03–1.10) <0.001
Type of hospital
Reference hospital 18 3.4 1.00 2 0.4 1.00 9.4 9.1 1.00
District hospital 52 7.1 2.24 (1.29–3.88) 0.004 4 0.5 1.30 (0.24–7.21) 0.761 8.7 13.0 0.92 (0.89–0.95) <0.001
High-technology general hospital 68 11.2 3.60 (2.10–6.16) <0.001 2 0.3 1.27 (0.17–9.21) 0.814 13.0 12.1 1.37 (1.32–1.42) <0.001
High-resolution hospital 51 10.1 3.20 (1.84–5.56) <0.001 4 0.8 2.24 (0.40–12.40) 0.356 8.1 7.4 0.86 (0.82–0.89) <0.001
Age 1.01 (1.00–1.02) 0.204 1.11 (1.04–1.20) 0.002 1.00 (1.00–1.00) 0.002
n: number of contacts with a positive indicator; % percentage of contacts with a positive indicator; mean: mean of the duration of days of contact. SD: standard deviation. aOR/Ratio
(CI95%): adjusted Odds Ratio/adjusted Ratio and 95% confidence Interval adjusted by the hospital-at-home modality, sex, age, comorbidity (Charlson index), and type of hospital;
p: p-value based on the multivariate model.
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4. Discussion
Our findings show that in 2014, in Catalonia, the results for readmission, mortality, and mean
length of stay for the two HaH modalities, in spite of their heterogeneous development, could be
similar to those observed in previous studies throughout the world [5–7,21]. In addition, irrespective
of the modality, it was observed that comorbidity and the type of hospital are related to readmission
and mean length of stay whilst the patient’s age is linked to mortality. Such information could serve as
a starting point to guide further research on causal relationships between the studied variables and the
results of HaH. This research could help more precisely define the most suitable healthcare circuits,
and the type of patients who could most benefit from the different HaH modalities.
Previous studies comparing HaH and CH [5,13,22,23] have reported that home care can have
similar results to CH and would save both human and economic resources [24–27]. In this sense, both
the results obtained and the available evidence suggest that, provided the patient’s indication permit
it and new causal research confirm them, HaH treatment could be a suitable, effective, and perhaps
efficient alternative to CH [10,21,25,28,29]. Furthermore, it should be noted that mental health contacts
were not included. Mental health HaH units have a strong psychosocial component involving further
than physicians and nurses, clinical psychologists, and social workers. Besides, HaH for mental health
usually is organized in a different way than for other conditions [5,30]. These differences make difficult,
and possibly biased, the comparison of outcomes between mental health HaH services with HaH
services for physical conditions. Despite these differences, new evidence focused on mental health,
could be valuable in assessing the results of HaH from a wider perspective.
Regarding the HaH modalities, we observed that whilst admission avoidance was more frequent
in less complex hospitals, the early discharge was more common in more complex ones. Despite
this, it is important to note that admission avoidance was applied more often than early discharge
in both types of hospitals. More complex or more serious cases could be addressed to a greater
extent in high-technology and high-resolution hospitals. These hospitals generally have a wide
range of technology and services, which results in a greater demand for healthcare. Thus, the results
obtained could allow the hypothesis that adopting an early assisted discharge program in hospitals
of greater complexity, providing the patient’s indication allows it, could result in the optimization
of services that are only available in these institutions. Besides, we can hypothesize that the use of
admission avoidance or early discharge schemes could have different outcomes for the treatment of
specific conditions [7,9,11]. Further causal studies centered on the early assisted discharge modality in
high-technology and high-resolution hospitals accounting for different specific diseases could help
assess the optimization of such specialized services.
With respect to the factors related to the considered outcomes, in both modalities, it was observed
that whilst readmission and mean length of stay were associated with the CCI and type of hospital,
mortality was related to the patient’s age. In addition, in the admission avoidance modality, mortality
was only related to comorbidity in patients with the highest CCI scores. Nevertheless, in spite of
being non-significant, the relationship in patients with a lower CCI was expected as found, possibly
predicting risk. In this manner, as reported by previous studies [6,31], our findings suggest that
comorbidity could be a particularly relevant factor when choosing this modality. Further longitudinal
studies aimed to compare both modalities with a greater sample size could be valuable in confirming
this hypothesis, and thus, better aid in the indication and improve the results. Moreover, readmissions
were considered globally (including subsequent contacts both of HaH and CH), and therefore, new
research accounting for the type of readmission could be relevant for the evaluation of HaH services.
As limitations of the study, it is worth highlighting the limitation related to the use of data from
2014. Despite this, since this year there are no significant changes in the characteristics of the study
population [15], we deem it reasonable to assume that the results could also be relevant currently.
Another limitation is the possible reductionism in which the classification of HaH modalities falls.
Nevertheless, this classification has been previously employed on numerous occasions when evaluating
HaH [6,7,23]. In addition, given the heterogeneity observed amongst the HaH units in Catalonia,
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it permits a general evaluation of the factors potentially related to their results at a population level.
Another limitation is related to the cross-sectional design of the study. It does not allow the direction
of the relationship amongst the variables to be established, precluding the establishment of causal
relationships between variables. Nevertheless, as our study is an exploratory analysis to find out what
factors could be related to the proposed outcomes, our results could serve to establish hypotheses on
causal relationships and could also be a starting point for future causal research. Furthermore, taking
into account the hospitals included, and their type, a multi-level structure of the data is suggested.
Despite this possible multi-level structure, our study could serve to determine the factors potentially
related to the outcomes selected globally (for the HaH modalities as a whole) and as a starting
point to further multi-level analyses. About the generalizability of the results, our study is focused
only in Catalonia, and therefore, the capability to extrapolate the results to other contexts might be
compromised. Nevertheless, as the HaH schemes are similar to those from other regions of Spain and
from other countries [6,7], the results could be, to a certain extent, extrapolated to these contexts. Lastly,
the limitation regarding the variables included should be mentioned. The inclusion of other variables
not considered related to the patient or hospital, like social support, length of contacts, or specific
treatments, could help more accurately define what factors could be associated with the indicators
that were analyzed. However, we consider that the included variables allow for the adjustment of
more parsimonious and easily interpretable models. In addition, these variables cover basic aspects of
both the patients and the care process, to a large extent, and an analysis of these factors is also a basic
previous step in conducting studies in greater depth.
5. Conclusions
In spite of the heterogeneity of HaH development in Catalonia, our findings in terms of readmission,
mortality, and mean length of stay are in line with previous studies in other settings [5–7,10]. In
addition, the results provide new evidence about which factors might be related to these results for
admission avoidance and early assisted discharge HaH modalities. Further causal research based
on the results obtained and taking other more specific HaH indicators into account, like cost-saving
with respect to the CH or freeing-up beds, could help define more precisely the type of patient and
care circuit, thus increasing the effectivity and efficiency of the different modalities. Therefore, this
study shows that HaH could be an effective and efficient healthcare modality to provide treatments for
patients eligible for it and, possibly, reducing costs for the healthcare systems.
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